Physician profile
Thomas B Paynter
NPI 1831234798
$13,892.31
in general payments reported to CMS, 2019-2025
12 companies · $4,292 in 2025
The $4,292 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,915 · 2020: $2,039 · 2021: $230 · 2022: $2,481 · 2023: $1,418 · 2024: $1,518 · 2025: $4,292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,038 · Food and Beverage: $2,548 · Education: $642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,037.78 |
| Food and Beverage | $2,548.43 |
| Education | $641.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,121.63 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Aequalis Perform Reversed |
| Arthrex, INC. | $4,488.93 | 2019-2025 | |
| Summit Surgical Corp. | $1,270.23 | 2020-2022 | |
| Wardlow Enterprises | $660.00 | 2019 | |
| Alaska Medical Technologies, LLC | $467.31 | 2025 | |
| Zimmer Biomet Holdings, INC. | $376.49 | 2021-2023 | Echo Press-Fit Hip System, Persona |
| Heron Therapeutics, INC. | $159.34 | 2022-2023 | Zynrelef |
| Fx Shoulder Solutions, INC | $123.65 | 2023 | |
| Kci USA, INC. | $74.42 | 2022 | |
| Ethicon US, LLC | $68.78 | 2021 | |
| Orthalign INC | $48.53 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $33.00 | 2025 | Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Paynter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.